Fingerprint
Dive into the research topics of 'Four‐drug combination chemotherapy in advanced lung cancer: Methotrexate, doxorubicin, cyclophosphamide and CCNU'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Four‐drug combination chemotherapy in advanced lung cancer: Methotrexate, doxorubicin, cyclophosphamide and CCNU
D. Milstein, E. Robinson
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations